Works matching AU Xu, Minhui


Results: 95
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.

    Published in:
    International Journal of Urology, 2018, v. 25, n. 4, p. 352, doi. 10.1111/iju.13521
    By:
    • Takei, Akinori;
    • Sakamoto, Shinichi;
    • Wakai, Ken;
    • Tamura, Takaaki;
    • Imamura, Yusuke;
    • Xu, Minhui;
    • Maimaiti, Maihulan;
    • Kawamura, Koji;
    • Imamoto, Takashi;
    • Komiya, Akira;
    • Akakura, Koichiro;
    • Ichikawa, Tomohiko
    Publication type:
    Article
    18

    The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90748-9
    By:
    • Maimaiti, Maihulan;
    • Sakamoto, Shinichi;
    • Sugiura, Masahiro;
    • Kanesaka, Manato;
    • Fujimoto, Ayumi;
    • Matsusaka, Keisuke;
    • Xu, Minhui;
    • Ando, Keisuke;
    • Saito, Shinpei;
    • Wakai, Ken;
    • Imamura, Yusuke;
    • Nakayama, Keiichi;
    • Kanai, Yoshikatsu;
    • Kaneda, Atsushi;
    • Ikehara, Yuzuru;
    • Ikeda, Jun-Ichiro;
    • Anzai, Naohiko;
    • Ichikawa, Tomohiko
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    The LAT1 inhibitor JPH203 suppresses the growth of castration‐resistant prostate cancer through a CD24‐mediated mechanism.

    Published in:
    Cancer Science, 2024, v. 115, n. 7, p. 2461, doi. 10.1111/cas.16191
    By:
    • Saito, Shinpei;
    • Ando, Keisuke;
    • Sakamoto, Shinichi;
    • Xu, Minhui;
    • Yamada, Yasutaka;
    • Rii, Junryo;
    • Kanaoka, Sanji;
    • Wei, Jiaxing;
    • Zhao, Xue;
    • Pae, Sangjon;
    • Kanesaka, Manato;
    • Goto, Yusuke;
    • Sazuka, Tomokazu;
    • Imamura, Yusuke;
    • Reien, Yoshie;
    • Hamaguchi‐Suzuki, Norie;
    • Saito, Shota;
    • Hirayama, Yuri;
    • Hashimoto, Hirofumi;
    • Kanai, Yoshikatsu
    Publication type:
    Article
    45

    L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.

    Published in:
    Cancer Science, 2024, v. 115, n. 3, p. 937, doi. 10.1111/cas.16062
    By:
    • Rii, Junryo;
    • Sakamoto, Shinichi;
    • Mizokami, Atsushi;
    • Xu, Minhui;
    • Fujimoto, Ayumi;
    • Saito, Shinpei;
    • Koike, Hidekazu;
    • Tamura, Takaaki;
    • Arai, Takayuki;
    • Yamada, Yasutaka;
    • Goto, Yusuke;
    • Sazuka, Tomokazu;
    • Imamura, Yusuke;
    • Suzuki, Kazuhiro;
    • Kanai, Yoshikatsu;
    • Anzai, Naohiko;
    • Ichikawa, Tomohiko
    Publication type:
    Article
    46
    47
    48
    49
    50